-
LL-37 Peptides Target MDR Acinetobacter baumannii and Biofil
2026-05-15
This study demonstrates that the human cathelicidin LL-37 and its fragments possess potent antimicrobial and antibiofilm activity against multidrug-resistant (MDR) Acinetobacter baumannii. The findings highlight the translational potential of LL-37-based strategies for combating difficult hospital-acquired infections.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Applicati
2026-05-14
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific detection of rabbit IgG in immunofluorescence, IHC, and related immunoassays. It is best suited for workflows requiring signal amplification and precise localization using Cy3 fluorescence. This antibody is not intended for diagnostic or medical use, nor for applications lacking established compatibility with Cy3-conjugated reagents.
-
EZ Cap EGFP mRNA 5-moUTP: Stable, Immune-Silent mRNA Deliver
2026-05-14
EZ Cap EGFP mRNA 5-moUTP from APExBIO is a Cap 1-capped, 5-methoxyuridine-modified mRNA that enables efficient, immune-evasive expression of enhanced green fluorescent protein. It delivers high translation efficiency and stability, supporting robust gene expression in vitro and in vivo. Verified protocols and benchmarks confirm its utility for mRNA delivery and translation efficiency assays.
-
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate
2026-05-13
This study reports the first efficient method for synthesizing deuterium-labeled degarelix acetate, a critical GnRH receptor antagonist for prostate cancer and androgen-related disease research. The described protocol enables the generation of stable isotope-labeled standards for advanced pharmacokinetic and metabolic studies.
-
Mitochondrial CAT-Tailing Drives Glioblastoma Growth via RQC
2026-05-13
This study uncovers how mitochondrial protein carboxyl-terminal alanine-threonine tailing (msiCAT-tailing), a ribosome-associated quality control response, enhances glioblastoma cell survival by promoting mitochondrial function and apoptosis resistance. The findings reveal a previously underappreciated metabolic adaptation in glioblastoma, offering new mechanistic insight and highlighting potential therapeutic targets.
-
IR-1061: Advancing Deep Tissue NIR Imaging for Translational
2026-05-12
Explore how IR-1061, a next-generation near infrared fluorescent dye from APExBIO, is reshaping in vivo imaging for translational researchers. This article integrates mechanistic insights from single-atom nanocatalytic therapies, protocol guidance, and a critical analysis of current deep-tissue imaging workflows to offer actionable, evidence-based strategies for biomedical innovation.
-
Ordered DNA Frameworks Boost Enzymatic Oligonucleotide Synth
2026-05-12
Li et al. introduce a highly ordered tetrahedral DNA nanostructure (TDN) interface to improve enzymatic oligonucleotide synthesis (EOS). This approach enhances enzyme accessibility and reduces synthesis errors, with significant implications for DNA data storage and precision genetic engineering.
-
EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Redefining Report
2026-05-11
Discover how Firefly Luciferase mRNA with 5-moUTP modification advances mRNA delivery and translation efficiency assays. This in-depth review uniquely examines molecular optimizations, recent LNP targeting breakthroughs, and robust design for reliable, low-immunogenicity bioluminescent reporter applications.
-
Sulfo-Cy3 Azide in Neurogenetic Birthdating: A Quantitative
2026-05-11
Explore the advantages of Sulfo-Cy3 azide as a bioconjugation reagent for precise neurogenetic birthdating and developmental mapping. This article delivers advanced assay guidance and shows how Sulfo-Cy3 azide transforms Click Chemistry fluorescent labeling in neuroscience.
-
Bispecific Anti-M1R/B6R Antibodies: Innovations in Orthopoxv
2026-05-10
This study systematically maps and characterizes monoclonal antibodies targeting the immunodominant M1R and B6R proteins of mpox virus, demonstrating that bispecific designs—especially those incorporating a VH-CH1 switch—markedly enhance antiviral efficacy in vitro and in vivo. These findings highlight promising antibody-based strategies for broad-spectrum orthopoxvirus therapeutics and inform future translational research.
-
Forsythoside E: Applied PKM2 Inhibitor Workflows in Immunome
2026-05-09
Forsythoside E, a potent pyruvate kinase M2 (PKM2) inhibitor, enables precise control over macrophage polarization and glycolytic flux—key for modeling sepsis-induced liver injury. This guide distills advanced use-cases, experimental workflows, and troubleshooting strategies for maximizing research outcomes with APExBIO’s high-purity Forsythoside E.
-
PD0325901 MEK Inhibitor: Protocols and Troubleshooting in Ca
2026-05-08
PD0325901 empowers researchers to dissect RAS/RAF/MEK/ERK signaling through highly selective MEK inhibition, enabling robust cell cycle arrest and apoptosis induction in preclinical models. This guide delivers actionable workflows, troubleshooting strategies, and practical insights for maximizing experimental reproducibility with APExBIO's PD0325901.
-
Bispecific Anti-M1R/B6R Antibodies for Orthopoxvirus Protect
2026-05-08
This study systematically characterized monoclonal antibodies against mpox virus immunogens M1R and B6R, identifying broadly neutralizing antibodies and innovating a bispecific antibody format with robust in vivo protection. These findings advance the rational design of antibody-based therapies for orthopoxvirus infections and provide a foundation for translational immunology workflows.
-
Mitochondrial CAT-Tailing Drives Glioblastoma Growth via Apo
2026-05-07
This study reveals that mitochondrial protein carboxyl-terminal alanine-threonine (CAT) tailing, a ribosome-associated quality control mechanism, promotes human glioblastoma progression by enhancing mitochondrial function and protecting against apoptosis. The work uncovers a mechanistic link between translational stress responses and tumor cell survival, offering new insights into therapeutic targeting of glioblastoma metabolism.
-
(-)-JQ1 in BRD4 Pathway Decoding: Negative Control, Real Imp
2026-05-07
Explore how (-)-JQ1, a pivotal JQ1 stereoisomer, enables precise dissection of BRD4-dependent pathways in advanced epigenetics and cancer biology research. This article uniquely bridges mechanistic insight with the latest assay innovations and practical best practices.